Academician: Battle pancreatic disease to benefit patients, offer 'Oriental Wisdom'
Share - WeChat
Emphasizing that innovation and internationalization are shared goals for both CAP and Hengrui Pharma, Zhao said this collaboration reflects a mutual commitment to scientific progress and national responsibility.
"By working together, the two sides can strive to overcome the greatest challenges in pancreatic disease prevention and treatment, a goal akin to that of mountaineers successfully scaling Mount Qomolangma," he said.
It has been learned that CAP and Hengrui Pharma will jointly promote international cooperation, support Asia-Pacific and global pancreatic disease summits, and organize branded academic conferences to enhance hospital management and oncology care capabilities.
- 6 injured after explosion at Hong Kong dockyard
- Spring snow blankets red plum blossoms in Guangping county, Hebei
- Intl faculty, students experience Chinese New Year flavors in Sanming
- Cementing rural foundation for Chinese modernization
- Field experts find balance of hard work and family tenderness
- Mountain quest reveals hidden riches
































